Elsevier Office of Continuing Medical Education and In Vivo Academy are developing a continuing medical education (CME) activity to support clinicians in making informed decisions about diagnostic tests and treatment choice in lymphoma based on accurate statistical interpretation of clinical trial results. The following survey, which will take less than 10 minutes to complete, aims to gain a comprehensive picture of your unmet educational needs in this area. Please help us identify priorities in developing the CME activity by completing the survey.

*
*
*
*
*
Very confidentConfidentSomewhat confidentNot at all confident
Overall survival (OS)
Progression free survival (PFS)
Event free survival (EFS)
Time to next treatment (TTNT)
Time to progression (TTP)
Progression of disease in 24 months (POD24)
Progression free survival in 24 months (PFS24)
Minimal residual disease (MRD)
Complete response at 30 months (CR30)
*

Following the completion of this survey we are keen to interview participants to better understand the educational gaps. If you are willing to be interviewed for no more than 15 minutes, please type in your name and contact details:

Thank you for your interest in this survey. Unfortunately at this time, you do not qualify to participate in this survey.